Supporting Patients Starting New Medicines: Evaluating the myCare Start Service in Switzerland

Patients Inclusion Criteria: * Must have mandatory basic health insurance in Switzerland * Must have been newly prescribed one or more new long-term medications in accordance with the following chronic conditions: cadisovascular diseases (incl. hyertension and thromboprophylaxis), diabetes, hyperlipidemia, depression, respiratory illness (asthma and COPD) * Must be able to self-manage treatment (i.e. they live at home without any support to manage their medication, exception: patient uses a pill dispenser and fills it in by him-/herself) * Must be able to understand language spoken by pharmacy staff and can read and understand study documents (French, German, English) * Must understand and are willing to consent to the myCare Start-I study (including the agreement on self-reported questionnaires and collection of health care data via their health insurance company) * in the intervention arm, patients must receive the myCare Start service For this study, a new medication is a medication that has not been previously dispensed to the patient. This includes one or more new medications for a new diagnosis and or new medications for pre-existing diagnosis of a long-term condition. Included in this working definition: * The new medication is indicated for one of the five long-term diseases listed above * Patient has never had this active ingredient dispensed before (patient still considered eligible if they have received a small initial sample pack from their physician) or resta…